|
|
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab
Julien Taieb
,
Aziz Zaanan
,
Karine Le Malicot
,
Catherine Julié
,
Hélène Blons
et al.
Journal articles
hal-01427989v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic factors of colorectal cancer patients with brain metastases
Pauline Roussille
,
Marie Auvray
,
Damien Vansteene
,
Thierry Lecomte
,
Eugénie Rigault
et al.
Journal articles
hal-03237457v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial
Julien Taieb
,
Valérie Taly
,
Julie Henriques
,
Camille Bourreau
,
Laurent Mineur
et al.
Journal articles
inserm-03405591v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
Thierry André
,
Dewi Vernerey
,
Laurent Mineur
,
Jaafar Bennouna
,
Jérôme Desramé
et al.
Journal articles
hal-01951156v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Simon Pernot
,
Cecile Badoual
,
Magali Terme
,
Florence Castan
,
Aurelie Cazes
et al.
Journal articles
hal-01579145v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
Franck Pagès
,
Thierry André
,
Julien Taieb
,
Déwi Vernerey
,
Julie Henriques
et al.
Journal articles
hal-02927418v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Involvement of the M-CSF/IL-34/CSF- 1R pathway in malignant pleural mesothelioma
Thibaut Blondy
,
Sènan Mickael d'Almeida
,
Tina Briolay
,
Julie Tabiasco
,
Clément Meiller
et al.
Journal articles
inserm-02913733v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus
Tiphaine Delaunay
,
Carole Achard
,
Nicolas Boisgerault
,
Marion Grard
,
Tacien Petithomme
et al.
Journal articles
inserm-02447160v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|